Voriconazole
NDC Package 61748-366-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Voriconazole is used to treat a variety of fungal infections. Marketed by Versapharm Incorporated, this product is identified by NDC 61748-366 and is authorized under FDA application ANDA207049.

Identification & Billing

NDC Package Code
61748-366-30
Package Description
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product Code
61748-366
11-Digit Billing Format
61748036630

Clinical Specifications

Proprietary Name
Voriconazole
Dosage Form
-
Usage Information
Voriconazole is used to treat a variety of fungal infections. It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.

Regulatory & Marketing

Labeler Name
Versapharm Incorporated
FDA Application #
ANDA207049
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-07-2016
End Marketing Date
09-08-2016
Listing Expiration
09-08-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61748-366-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle, plastic of Voriconazole, labeled by Versapharm Incorporated. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Versapharm Incorporated on September 07, 2016. The current certification is valid through September 08, 2016.

What are the primary indications for this medication?

Voriconazole is used to treat a variety of fungal infections. It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.

How is this Versapharm Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61748036630. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61748-366-30
11-Digit CMS (5-4-2)
61748-0366-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.